A Philadelphia jury has ordered scientific company Johnson & Johnson to pay $8 billion greenbacks in punitive damages in the case of a man who said he developed breasts after taking the corporate’s anti-psychotic drug Risperdal as a baby. The case is unrelated to a string of mountainous-money court cases the corporate is going by map of over its signature minute one powder.
In the Risperdal case, a jury stumbled on that Johnson & Johnson failed to warn 26-year-aged Nicholas Murray of the drug’s facet effects. Murray claimed that taking the Risperdal as a baby brought on him to construct breasts, an incurable situation diagnosed as gynecomastia. 1000’s of others maintain filed court cases alleging the same.
Murray said he became once prescribed the treatment at age 9 for symptoms associated to autism spectrum dysfunction, no topic the fact that the FDA’s approval of the drug in the Nineties became once to deal with schizophrenia and episodes of bipolar mania in adults.
Attorneys for Murray alleged the corporate marketed the drug for unapproved, off-label use in kids to elongate profits, deciding on “billions over kids.”
Johnson & Johnson denied the allegations, and said it is assured the ruling will likely be overturned. In an announcement, the corporate said it became once “precluded from presenting … key proof…” The company additional claimed that proof showed how the label for the drug “clearly and as it will likely be outlined the dangers associated with the treatment.”
Murray’s attorneys urged “CBS This Morning” particular person investigative correspondent Anna Werner that the punitive damages were meant to deter the corporate from an identical habits in the kill. They enjoy the choice will stand.
© 2019 CBS Interactive Inc. All Rights Reserved.